U.S. Online Retail and Ecommerce Stock News

In early January 2026, Commercial Metals Company reported first-quarter 2026 results showing sales of US$2,120.31 million and net income of US$177.28 million, a sharp turnaround from a net loss a year earlier, and its board also declared a regular quarterly cash dividend of US$0.18 per share, marking the company’s 245th consecutive quarterly payout. Alongside this earnings rebound and ongoing dividend record, recent acquisitions in precast concrete and pipe products plus fresh insider share...

Earlier this month, Shake Shack updated its preliminary unaudited guidance, flagging weather-related pressure on fourth-quarter 2025 sales while projecting about US$400.5 million in Q4 revenue, US$1.45 billion for full-year 2025, and US$1.60 billion–US$1.70 billion with US$50 million–US$60 million in net income for 2026. Despite the short-term sales hit, management underscored a record expansion plan of 55–60 new company-operated Shacks in 2026 and reaffirmed long-term growth targets,...

Diversified Healthcare Trust recently declared a regular quarterly cash distribution of US$0.01 per share, payable on or about February 19, 2026, and received US$27.2 million from AlerisLife’s asset sale and wind-down, with a further US$3 million to US$7 million expected. Together with the completed transition of all former Five Star communities to seven new operators and extensive non-core property sales, these cash inflows highlight DHC’s efforts to reshape its senior housing portfolio and...

CNH Industrial (CNH) is back in focus after several banks issued more constructive views on the stock, together with New Holland’s T7.440XD tractor launch, which are reshaping how investors are reassessing the company. See our latest analysis for CNH Industrial. Those upbeat bank views and the T7.440XD launch come after a solid 15.72% year to date share price return from CNH Industrial to US$10.82, even though the 1 year total shareholder return of 8.53% and 3 year total shareholder return of...

Government funded research questioning how US marijuana DUI laws assess impairment is drawing fresh attention to legal risks around cannabis use and enforcement, a backdrop many investors are watching for Innovative Industrial Properties (IIPR). See our latest analysis for Innovative Industrial Properties. At a share price of US$50.81, IIPR has a 7 day share price return of 1.91%, but a 30 day share price return decline of 12.61%. Its 1 year total shareholder return decline of 12.85% and 5...

SLM (SLM) is back in focus after a wave of securities class action lawsuits and fresh analyst downgrades tied to concerns about early stage delinquencies, loss mitigation practices, and disclosure quality. See our latest analysis for SLM. At a share price of US$26.99, SLM has seen pressure in the short term, with a 7 day share price return of 3.37% decline and a modest 90 day share price return of 5.06%. The 3 year total shareholder return of 79.96% and 5 year total shareholder return of...

Healthcare Realty Trust has appointed Daniel Gabbay as Chief Financial Officer and Executive Vice President, effective January 12, 2026, succeeding outgoing CFO Austen Helfrich, whose departure was not related to any disagreement with management or auditors. Gabbay brings nearly two decades of healthcare-focused real estate investment banking experience, including advising on multi-billion-dollar REIT combinations, which may influence how Healthcare Realty Trust approaches capital markets...

BWX Technologies: recent performance snapshot BWX Technologies (BWXT) has drawn fresh attention after a strong recent run in its share price, with the stock up 10.4% over the past week and 23.1% over the past month. That short term strength comes on top of a 4.5% gain over the past 3 months and a 77.4% total return over the past year, putting recent performance firmly on investors’ radar. See our latest analysis for BWX Technologies. The recent 1 month share price return of 23.1% and 1 year...

Wave Life Sciences (WVE) has been back on investors’ radar after early data for its RNA obesity candidate WVE-007 showed meaningful fat loss with muscle preservation, along with plans to start a Phase 2a multidose trial in early 2026. See our latest analysis for Wave Life Sciences. The recent excitement around WVE-007 and the 2026 pipeline plans helped drive a very strong 90 day share price return of 80.15%, even though the 30 day share price return of 14.26% and year to date share price...

Recent attention on Futu Holdings (FUTU) has been sparked by its reported financial results, which include revenue and user growth, high operating margins, and international adoption across its Futubull and Moomoo trading platforms. See our latest analysis for Futu Holdings. At a share price of $176.5, Futu has a 1 month share price return of 8.02% and a 3 month share price return of 7.93%. Its 1 year total shareholder return of 119.53% and 3 year total shareholder return of roughly 2.5x...

If you are wondering whether QuidelOrtho at around US$35.38 is starting to look like value or a value trap, you are not alone. That is exactly what this piece will unpack. The stock has returned 5.6% over the last 7 days and 22.5% over the last 30 days, yet year to date it is at 22.9% with a 1 year return of 15.5% decline and a 3 year return of 59.0% decline, compared with a 5 year return of 83.8% decline. These moves sit against a backdrop where QuidelOrtho continues to attract attention...

Recent analyst updates have pushed Elevance Health (ELV) into focus, as firms referenced survey data suggesting healthcare utilization growth may be slowing. They interpret this as a possible peak in recent demand trends. See our latest analysis for Elevance Health. The recent analyst commentary has arrived against a backdrop of improving momentum, with a 30 day share price return of 8.53% and a 90 day share price return of 9.51% at a latest share price of $381.93. Over a longer window, the 1...

Frontline (FRO) is in the spotlight after announcing a fleet renewal plan that combines the sale of older VLCCs with the acquisition of nine scrubber fitted ECO VLCC newbuildings, attracting fresh investor attention. See our latest analysis for Frontline. The fleet renewal news comes after a strong run, with a 30 day share price return of 15.38% and a year to date gain of 26.09%. The 1 year total shareholder return of 55.51% and very large 5 year total shareholder return suggest momentum has...

Recently, HSBC analyst Sean McLoughlin upgraded Eaton to a buy rating, citing rising demand for equipment to power artificial intelligence data centers as a key growth driver, while other research highlighted both its exposure to technology-driven end markets and ongoing industry headwinds. This focus on Eaton’s role in AI data center infrastructure, alongside commentary about global reindustrialization and energy-efficient technologies, underscores how power management has become central to...

Old Second Bancorp recently reported a very strong quarter, with revenues exceeding analyst expectations and continued support from a favorable regional banking backdrop. At the same time, the bank’s net interest income and margin remain robust even as overall revenue growth has cooled, highlighting a business increasingly driven by loan profitability and funding discipline. Now we’ll consider how this earnings strength, particularly the resilient net interest margin, reshapes Old Second...

AllianceBernstein Holding (AB) has drawn fresh attention after recent trading left the units near $39.25, with mixed returns over the past month and past 3 months prompting investors to reassess the asset manager’s profile. See our latest analysis for AllianceBernstein Holding. At around $39.25, the recent 7 day share price return of 2.21% contrasts with a softer 30 day share price return of a 1.51% decline, while the 1 year total shareholder return of 16.63% and 5 year total shareholder...

What Assurant’s recent earnings momentum and leadership move could mean for investors Assurant (AIZ) heads into its next earnings report in February after two consecutive quarters of earnings that topped analyst estimates, a backdrop now paired with a fresh leadership shift in Connected Living. See our latest analysis for Assurant. Assurant’s share price has risen 13.55% over the past 90 days and its 1 year total shareholder return of 13.90% sits alongside a 3 year total shareholder return...

Earlier this month, OGE Energy’s utility subsidiary OG&E created a new Commercial organization and appointed John Laws as chief commercial officer to lead customer engagement, systems planning, and sales across Oklahoma and western Arkansas. This move signals a stronger emphasis on tailored energy solutions and customer experience, which could influence how OG&E captures future demand and manages its service offerings. We’ll now examine how the creation of this new Commercial organization...

Popular (BPOP) is back on income investors’ radar after declaring its latest monthly payments on preferred shares and trust preferred securities, a move that puts its capital structure and yield profile in focus. See our latest analysis for Popular. The latest preferred and trust preferred payouts come as Popular’s common shares trade at US$128.84, with a 30-day share price return of 5.76% and a 1-year total shareholder return of 34.10%. The 5-year total shareholder return of 150.72% points...

If you are wondering whether Royal Caribbean Cruises at around US$278 per share still offers value after a strong multi year run, the key is to look closely at what the current price implies about the future. The stock has had a mixed recent run, with an 8.6% decline over the last week and a 1.2% decline over the last month, yet it is still up 20.7% over the past year and has delivered a very large 3 year return and 289.5% over 5 years. Recent headlines around Royal Caribbean Cruises have...

Why Lisa P. Sawicki’s Board Appointment Matters for Moody's Stock Moody's (MCO) has added Lisa P. Sawicki to its Board of Directors, with her audit and financial services background feeding directly into the Audit and Governance & Nominating Committees from March 16, 2026. For you as a shareholder or prospective investor, this kind of board change is less about short term headlines and more about how risk oversight, accounting scrutiny, and long term decision making might evolve at a company...

CareDx recently issued preliminary, unaudited guidance for fourth quarter and full year 2025, projecting approximately US$108 million in Q4 revenue and about US$380 million for the year, both reflecting solid year-over-year increases. This guidance, alongside CareDx’s ongoing Transplant+ innovation efforts, highlights how growing demand across testing, digital solutions, and products is reinforcing its transplant-focused business model. We’ll now examine how this stronger-than-expected 2025...

Lithia Motors recently delivered a quarterly update showing revenue ahead of analyst forecasts, with management pointing to stronger same-store sales, earnings per share, and profitability gains driven by its ongoing execution focus. At the same time, concerns around lagging same-store sales over the past two years, thin gross margins, and a high net-debt-to-EBITDA ratio highlight that Lithia’s operational progress is occurring alongside meaningful balance sheet and competitive...

UDR (UDR) shares are in focus after the company appointed veteran auditor Ellen M. Goitia as an independent director, expanding the board to ten members and adding experience in both governance and risk oversight. See our latest analysis for UDR. UDR’s latest share price of $37.08 comes after a 1 month share price return of 4.57% and a 3 month gain of 2.74%. The 1 year total shareholder return of a 6.31% decline contrasts with a 5 year total shareholder return of 14.44%, suggesting that near...